🇰🇷 Brinsupri in South Korea

Brinsupri (BRENSOCATIB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Brinsupri in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in South Korea

Frequently asked questions

Is Brinsupri approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Brinsupri in South Korea?

Insmed Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.